1Scalera NM,Mossad SB.The first pandemic of the 21st century:a review of the 2009 pandemic variant influenza A (H1N1) virus[J].Postgrad Med,2009,121(5):43-47.
2Simonsen L,Reichert TA,Viboud C,et al.Impact of influenza vaccination on seasonal mortality in the US elderly population[J].Arch Intern Med,2005,165(3):265-272.
3Echevarría-Zuno S,Mejía-Aranguré JM,Mar-Obeso AJ,et al.Infection and death from influenza A H1N1 virus in Mexico:a retrospective analysis[J].Lancet,2009,374(9709):2072-2079.
5Liang XF,Wang HQ,Wang JZ,et al.Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China:a multicentre,double-blind,randomised,placebo-controlled trial[J].Lancet,2010,375(9708):56-66.
6Vajo Z,Tamas F,Sinka L,et al.Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season:a multicentre,randomised controlled trial[J].Lancet,2010,375(9708):49-55.
7Plennevaux E,Sheldon E,Blatter M,et al.Immune response after a single vaccination against 2009 influenza A H1N1 in USA:a preliminary report of two randomised controlled phase 2 trials[J].Lancet,2010,375(9708):41-48.
8Kelly H,Barr I.Large trials confirm immunogenicity of H1N1 vaccines[J].Lancet,2010,375(9708):6-9.
9Simonsen L,Taylor RJ,Viboud C,et al.Mortality benefits of influenza vaccination in elderly people:an ongoing controversy[J].Lancet Infect Dis,2007,7(10):658-666.
二级参考文献3
1NichoI KL Complications of influenza and benefits of vaccination [J]. Vaccine, 1999,6 : 30.
2Nichol KL. The additive benefits of influenza and pneumococcal vaccinations during influenza seasons among elderly persons with chronic lung disease[J]. Vaccine, 1999,7:30.
